Archean Chemical Industries Limited (ACI) Earnings Call Transcripts

40 earnings calls from January 2020 to August 3, 2026

NSEI IN Materials Chemicals

Archean Chemical Industries Limited's Latest Earnings Call - Q4 FY2026

Albertsons Companies, Inc. reported its fourth quarter and full year 2025 earnings, highlighting a better-than-expected adjusted EBITDA of $903 million despite pharmacy headwinds. Identical sales increased by 0.7% in Q4, with full-year results aligning with expectations. Management announced a 13% increase in the quarterly dividend and a refreshed $2 billion share repurchase authorization, signaling confidence in fiscal 2026. Revenue guidance for 2026 is set at 0% to 1% identical sales growth, excluding a 150 basis point headwind from the Inflation Reduction Act. Adjusted EPS is projected between $2.22 and $2.32.

Reported metrics

MetricValueContext
Adjusted EBITDA $903 million (beat) beat expectations despite pharmacy headwinds
Identical Sales Growth 0.7% (miss) impacted by 145 basis points of pharmacy headwinds
Gross Margin 27.2% (miss) decline of 25 basis points YoY, excluding fuel and LIFO
Adjusted EPS $0.48 (beat) despite industry-wide pharmacy dynamics
Digital Penetration 10% (positive) new milestone for omnichannel ecosystem
Dividend Increase 13% (positive) to $0.68 per share

Guidance from management

For fiscal 2026, Albertsons expects identical sales growth of 0% to 1%, excluding a 150 basis point headwind from the Inflation Reduction Act. Adjusted EPS is projected between $2.22 and $2.32, with $600 million in share repurchases planned.

What management said

Yes, we just reset our productivity to $2 billion over the next 3 years. You can think of that ratably over that period of time. And when you look at the big areas that, that comes out of, it's going to be our store operations, including shrinkage and Rx, you're going to see us buying better together. Sourcing, both GNFR and in the admin areas, we expect to see benefit supply chain. So we have amplified our activitie...
— Sharon McCollam, Q4 FY2026 earnings call
Leah, what I would add to that is that the strength of the productivity really shown through for us in FY '25. We showed that we can fund strong investments, still deliver EBITDA. And as Sharon mentioned, as we think about the shape of productivity moving forward, the fact that we raised our expectations there from $1.5 billion to $2 billion over the next 3 years, that shows that we believe there's more to be had. ...
— Susan Morris, Q4 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns about the impact of higher fuel prices due to geopolitical tensions and the potential need for deeper pricing investments in competitive markets. Additionally, there were questions about the sustainability of productivity gains and the implications of GLP-1 moderation on store traffic.

Main topics on the call

Read the full Archean Chemical Industries Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Archean Chemical Industries Limited

Archean Chemical Industries Limited (ACI) is a publicly listed company in the Chemicals industry, within the Materials sector. It trades on NSEI and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 40 calls on record spanning January 7, 2020 to August 3, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 40 Archean Chemical Industries Limited earnings call transcripts on record, spanning January 7, 2020 to August 3, 2026. Based on this history, Archean Chemical Industries Limited reports quarterly. The most recent call on file is dated August 3, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
ACI
Exchange
NSEI
Country
IN
Sector
Materials
Industry
Chemicals
Calls on record
40
First call
January 7, 2020
Most recent
August 3, 2026
Reporting cadence
quarterly
Quarter Date
Q1 FY2027 Aug 3, 2026 Read transcript
Q1 FY2027 Jul 23, 2026 Read transcript
Q4 FY2026 May 13, 2026 Read transcript
Q4 FY2026 Apr 14, 2026 Read transcript
Q3 FY2026 Feb 6, 2026 Read transcript
Q3 FY2026 Jan 7, 2026 Read transcript
Q2 FY2026 Oct 14, 2025 Read transcript
Q1 FY2026 Jul 15, 2025 Read transcript
Q4 FY2025 May 7, 2025 Read transcript
Q4 FY2025 Apr 15, 2025 Read transcript
Q3 FY2025 Feb 12, 2025 Read transcript
Q3 FY2025 Jan 8, 2025 Read transcript
Q2 FY2025 Nov 12, 2024 Read transcript
Q1 FY2025 Aug 5, 2024 Read transcript
Q4 FY2024 May 17, 2024 Read transcript
Q3 FY2024 Feb 6, 2024 Read transcript
Q1 FY2023 Jul 26, 2022 Read transcript
Company Conference Presentations Jun 2, 2022 Read transcript
Q4 FY2022 Apr 12, 2022 Read transcript
Q3 FY2022 Jan 11, 2022 Read transcript
Q2 FY2022 Oct 18, 2021 Read transcript
Company Conference Presentations Sep 10, 2021 Read transcript
Q1 FY2022 Jul 29, 2021 Read transcript
Company Conference Presentations Jun 15, 2021 Read transcript
Company Conference Presentations Jun 15, 2021 Read transcript
Company Conference Presentations Jun 3, 2021 Read transcript
Company Conference Presentations Jun 3, 2021 Read transcript
Company Conference Presentations May 19, 2021 Read transcript
Q4 FY2021 Apr 26, 2021 Read transcript
Company Conference Presentations Mar 19, 2021 Read transcript
Company Conference Presentations Mar 10, 2021 Read transcript
Q3 FY2021 Jan 12, 2021 Read transcript
Special Calls Dec 7, 2020 Read transcript
Company Conference Presentations Dec 3, 2020 Read transcript
Q2 FY2021 Oct 20, 2020 Read transcript
Company Conference Presentations Sep 9, 2020 Read transcript
Special Calls Aug 27, 2020 Read transcript
Q1 FY2021 Jul 27, 2020 Read transcript
Q4 FY2020 Apr 30, 2020 Read transcript
Q3 FY2020 Jan 7, 2020 Read transcript